Why the study?
Does oral L-carnitine supplementation reduce myocardial lipid accumulation in LCAD knockout mice?
Population
Long-chain acyl-CoA dehydrogenase knockout mice and wild-type mice, starting at 5 weeks of age.
Comparison
Oral L-carnitine supplementation for 4 weeks. vs Non-supplemented animals.
Design
Preclinical
Follow-up
4 weeks
Authors
Loading...
Hypothesis-generating for carnitine in LCAD deficiency; leaves open translation to human fatty acid oxidation disorders.
Does oral L-carnitine supplementation reduce myocardial lipid accumulation in LCAD knockout mice?
Carnitine supplementation safely normalizes myocardial triglyceride levels in a mouse model of long-chain fatty acid oxidation deficiency.
Bakermans et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: